We are live on
!
Find out more
Rockefeller Capital Management Portfolio holdings
AUM
$56.4B
1-Year Est. Return
24.96%
This Fund
S&P 500
This Quarter
Est. Return
-0.57%
1 Year Est. Return
+24.96%
3 Year Est. Return
+83.53%
5 Year Est. Return
+100.91%
10 Year Est. Return
–
AUM
$19B
AUM Growth
+$1.28B
(+7.2%)
Cap. Flow
+$1.55B
Cap. Flow
% of AUM
8.12%
Top 10 Holdings %
Top 10 Hldgs %
20.03%
Holding
3,992
New
448
Increased
1,822
Reduced
816
Closed
180
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elanco Animal Health
ELAN
|
+$89.1M |
| 2 |
WEX
WEX
|
+$78.4M |
| 3 |
Blackrock
BLK
|
+$73.2M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$71.9M |
| 5 |
OneMain Financial
OMF
|
+$45.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$63.6M |
| 2 |
Neurocrine Biosciences
NBIX
|
+$56.6M |
| 3 |
Agnico Eagle Mines
AEM
|
+$55.1M |
| 4 |
DFS
Discover Financial Services
DFS
|
+$36M |
| 5 |
ORBC
ORBCOMM, Inc.
ORBC
|
+$27.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.39% |
| 2 | Financials | 14.65% |
| 3 | Healthcare | 12.11% |
| 4 | Consumer Discretionary | 7.54% |
| 5 | Industrials | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Ionis Pharmaceuticals
IONS
$9.01B
| $44.7M | 0.23% |
1,332,780
+8,169
| +0.6% | +$308K |
|
102
Texas Instruments
TXN
$254B
| $44.5M | 0.23% |
231,511
+7,598
| +3% | +$1.45M |
|
103
Goldman Sachs
GS
$313B
| $44M | 0.23% |
116,277
+21,460
| +23% | +$8.38M |
|
104
AbbVie
ABBV
$435B
| $43.7M | 0.23% |
404,919
+51,054
| +14% | +$5.83M |
|
105
Merit Medical Systems
MMSI
$5.21B
| $43.3M | 0.23% |
603,035
-6
| -0% | -$407 |
|
106
Intuitive Surgical
ISRG
$133B
| $43.3M | 0.23% |
130,611
-3,045
| -2% | -$1.02M |
|
107
Tetra Tech
TTEK
$8.78B
| $43.3M | 0.23% |
1,449,110
+25,860
| +2% | +$710K |
|
|
108
OneMain Financial
OMF
$7.54B
| $43.1M | 0.23% |
778,812
+778,597
| +362,138% | +$45.3M |
|
109
United Parcel Service
UPS
$91.5B
| $42.8M | 0.22% |
235,108
+8,584
| +4% | +$1.69M |
|
110
Factset
FDS
$9.89B
| $41.8M | 0.22% |
105,790
+952
| +0.9% | +$346K |
|
111
American Tower
AMT
$78.3B
| $41M | 0.22% |
154,314
+7,446
| +5% | +$2.12M |
|
112
Target
TGT
$67.1B
| $40.7M | 0.21% |
178,030
+23,697
| +15% | +$5.94M |
|
113
Insulet
PODD
$9.23B
| $40.7M | 0.21% |
143,095
+958
| +0.7% | +$273K |
|
114
Vanguard Morningstar Growth ETF
VUG
$230B
| $40.5M | 0.21% |
837,078
+188,832
| +29% | +$9.4M |
|
115
iShares TIPS Bond ETF
TIP
$14.5B
| $40.1M | 0.21% |
314,000
+7,794
| +3% | +$1M |
|
116
iShares Core MSCI Emerging Markets ETF
IEMG
$156B
| $39.6M | 0.21% |
641,219
+43,339
| +7% | +$2.76M |
|
|
MASI
117
DELISTED
Masimo
MASI
| $39.4M | 0.21% |
145,493
+731
| +0.5% | +$198K |
|
118
Badger Meter
BMI
$4.04B
| $39.3M | 0.21% |
388,625
+6,963
| +2% | +$712K |
|
119
BridgeBio Pharma
BBIO
$16.1B
| $39.2M | 0.21% |
836,914
+4,830
| +0.6% | +$259K |
|
120
Lowe's Companies
LOW
$123B
| $38.9M | 0.2% |
191,926
+24,690
| +15% | +$4.92M |
|
121
Coca-Cola
KO
$374B
| $38.6M | 0.2% |
736,468
+99,318
| +16% | +$5.54M |
|
122
Automatic Data Processing
ADP
$107B
| $38.4M | 0.2% |
191,896
+11,218
| +6% | +$2.31M |
|
123
Littelfuse
LFUS
$11.7B
| $38M | 0.2% |
139,226
+660
| +0.5% | +$176K |
|
124
Colgate-Palmolive
CL
$74.4B
| $37.7M | 0.2% |
499,254
+4,376
| +0.9% | +$347K |
|
125
Lockheed Martin
LMT
$133B
| $37.7M | 0.2% |
109,179
+3,189
| +3% | +$1.15M |
|
Similar funds
NAMI
Rockefeller Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Rockefeller Capital Management held 3,992 positions worth $19B, up 7.2% from $17.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Rockefeller Capital Management deployed $1.55B of net new capital in Q3 2021, opening 448 new positions and adding to 1,822 existing holdings. Its largest new stake was Darling Ingredients: 56,725 shares worth $4.08M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $63.6M trimmed.
- Rockefeller Capital Management's largest Q3 2021 buy was Darling Ingredients: 56,725 shares worth $4.08M.
- Rockefeller Capital Management added most to Elanco Animal Health in Q3 2021, an estimated $89.1M increase.
- Rockefeller Capital Management's biggest Q3 2021 reduction was Regeneron Pharmaceuticals, cutting an estimated $63.6M.
- Rockefeller Capital Management fully exited ORBCOMM, Inc. in Q3 2021, selling an estimated $27.5M.
- Rockefeller Capital Management's ten largest holdings make up 20% of its $19B portfolio in Q3 2021.
- Rockefeller Capital Management opened 448 new positions and closed 180 in Q3 2021.
- Rockefeller Capital Management's portfolio value rose 7.2% quarter-over-quarter to $19B.
Based on Rockefeller Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.